Sutro Biopharma

STRO

Capitalización de mercado USD 159 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Suvretta Capital Management New York	USD 5.63 M	–	–	–
2	KCM 2 Kynam Capital Management Princeton, New Jersey	USD 4.42 M	–	–	–
3	3 Millennium Management New York	USD 3.93 M	-USD 177 k	-20,789	-4%
4	4 Vanguard Group Malvern, Pennsylvania	USD 3.2 M	-USD 368 k	-43,226	-11%
5	5 Acadian Asset Management Boston, Massachusetts	USD 2.94 M	+USD 295 k	+34,708	+11%
6	6 Velan Capital Investment Management Alpharetta, Georgia	USD 2.71 M	+USD 51.1 k	+6,000	+2%
7	7 Tang Capital Management San Diego, California	USD 2.46 M	+USD 227 k	+26,713	+10%
8	8 Merck & Co Rahway, New Jersey	USD 2.37 M	–	–	–
9	9 Vestal Point Capital New York	USD 2.26 M	–	–	–
10	10 Eversept Partners New York	USD 1.99 M	-USD 808	-95	-0%
11	11 Samsara BioCapital Palo Alto, California	USD 1.91 M	–	–	–
12	12 Adage Capital Partners Boston, Massachusetts	USD 1.74 M	–	–	–
13	13 UBS Group Zurich, Switzerland	USD 1.6 M	+USD 193 k	+22,696	+14%
14	14 BlackRock New York	USD 1.47 M	-USD 357 k	-41,913	-20%
15	15 Renaissance Technologies New York	USD 1.24 M	+USD 435 k	+51,160	+56%
16	16 Geode Capital Management Boston, Massachusetts	USD 713 k	+USD 3.43 k	+403	+0.5%
17	17 Affinity Asset Advisors New York	USD 654 k	–	–	–
18	18 Jacobs Levy Equity Management Florham Park, New Jersey	USD 387 k	+USD 379 k	+44,575	Nuevas
19	19 DAFNA Capital Management Los Angeles, California	USD 380 k	–	–	–
20	20 Two Sigma Investments New York	USD 345 k	+USD 240 k	+28,172	+245%
21	21 AQR Capital Management Greenwich, Connecticut	USD 308 k	-USD 560 k	-65,827	-65%
22	22 Fisher Asset Management Camas, Washington	USD 306 k	–	–	–
23	23 State Street Boston, Massachusetts	USD 298 k	–	–	–
24	24 Shay Capital New York	USD 271 k	+USD 44.4 k	+5,216	+20%
25	25 Royal Bank of Canada Toronto, Ontario, Canada	USD 225 k	+USD 31.6 k	+3,716	+17%

Sutro Biopharma STRO Capitalización de mercado USD 159 M

Sutro Biopharma

STRO

Capitalización de mercado USD 159 M